Core Laboratories Inc. (CLB) stock
CLBNYSEOil & Gas Field Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3010% above fair value
$9.11+0.10 (+1.11%)
Close on Nov 13, 2026Market cap $417.45MP/E 26.8Yield 0.44%
Core Laboratories total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Core Laboratories's total debt was $112.45M at Sep 30, 2026. For fiscal 2025 it was $110.26M, down 12.6% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $110.26M | -12.6% |
| FY2024 | Dec 31, 2024 | $126.11M | -22.7% |
| FY2023 | Dec 31, 2023 | $163.13M | -5.4% |
| FY2022 | Dec 31, 2022 | $172.39M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $112.45M | -1.5% |
| Q2 FY2026 | Jun 30, 2026 | $113.86M | -8.6% |
| Q1 FY2026 | Mar 31, 2026 | $114.46M | -8.0% |
| Q4 FY2025 | Dec 31, 2025 | $110.26M | -12.6% |
| Q3 FY2025 | Sep 30, 2025 | $114.10M | -18.4% |
| Q2 FY2025 | Jun 30, 2025 | $124.61M | -15.6% |
| Q1 FY2025 | Mar 31, 2025 | $124.37M | -22.4% |
| Q4 FY2024 | Dec 31, 2024 | $126.11M | -22.7% |
| Q3 FY2024 | Sep 30, 2024 | $139.87M | -21.4% |
| Q2 FY2024 | Jun 30, 2024 | $147.62M | -19.1% |
| Q1 FY2024 | Mar 31, 2024 | $160.37M | -7.0% |
| Q4 FY2023 | Dec 31, 2023 | $163.13M | – |
| Q3 FY2023 | Sep 30, 2023 | $177.86M | – |
| Q2 FY2023 | Jun 30, 2023 | $182.58M | – |
| Q4 FY2022 | Dec 31, 2022 | $172.39M | – |
See a number that looks wrong?